AzTrials
AzTrials

Colonoscopy ProcedurePhase 4KALINAGNCT00930358

Safety Study of Colonoscopy Under Sedation

A Phase 4 study testing MEOPA and general anaesthesia in people with Colonoscopy Procedure, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The aim of this study was to compare the analgesia provided by nitrous oxide/oxygen sedation or general anesthesia for colonoscopy Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Colonoscopy Procedure
What is being tested?
MEOPA and general anaesthesia
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
220 participants
Where
1 siteFrance
Study dates
Feb 2009to Jan 2011
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient referred for colonoscopy with general anesthesia
  • Age above 18 et below 75 year
  • Patient who gave an informed consent

Who cannot join

  • Age below 18 ou above 75
  • Need for gastroscopy in the same procedure than colonoscopy
  • History of surgery wih resection more extended than half of the colon
  • Dementia with autonomy loss or psychiatric disorder non controlled by therapeutic
  • Severe congestive heart failure or evolutive heart ischemia
  • Recent cerebral stroke
Show all 11Show fewer
  • Hemodynamic instability
  • Respiratory failure, severe chronic obstructive pulmonary (including asthma) or progressive pneumothorax
  • Hepatic failure (Child-Pugh score> 9)
  • Terminal renal failure 11 Hematopoietic disorders
  • 12. Pathology with expected survival shorter than the duration of the study and cancer excepted basal cell carcinoma of the skin 13. Alcohol consumption higher than 100 gr per day 14. Pregnancy or breastfeeding at the inclusion period

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hotel Dieu Hospital

    Paris, 75004

Other trials in France

About this study

Official title: Tolerance and Acceptability of Colonoscopy Under Sedation by an Equimolar Mixture of Oxygen and Nitrous Oxide. Comparison With General Anesthesia in a Randomized, Multicentric Study.

The aim of this study was to compare the analgesia provided by nitrous oxide/oxygen sedation or general anesthesia for colonoscopy

Read the detailed description

The purpose of this protocol is to compare two methods of analgesia/sedation for colonoscopy. Sedation and analgesia induced by a 50% nitrous oxide/oxygen mixture could sufficient to allow the practice of colonoscopy instead of general anesthesia which is accompanied with certain risks and post procedure drowsiness.

Being tested
MEOPA, general anaesthesia
Keywords
Sedation, Colonoscopy, General anesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MEOPADrug

    Also called anaesthetic gaz inhalation

    anaesthetic gaz inhalation

  • general anaesthesiaDrug

    Also called Anaesthetic intravenous route

    Anaesthetic intravenous route

Study groups in NCT00930358
Study groupRoleWhat they receive
MEOPAExperimentalMEOPA : equimolar nitrous oxide/oxygen mixture
Receives: Drug: MEOPA
General anesthesiaActive comparatorGold standard
Receives: Drug: general anaesthesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of patients who have well tolerated the colonoscopy as assessed by visual analogic scale (>75/100)

    Measured: Immediately after the colonoscopy

  2. The mean grade of patient anxiety before endoscopy

    The mean grade of patient anxiety before endoscopy

    Measured: After the colonoscopy

Secondary outcomes (12)
  1. The mean tolerability of the colonoscopy between the group with sedation by nitrous oxide/oxygen mixture and the group with anesthesia

    Measured: after the colonoscopy

  2. The mean pain intensity during the procedure on a visual analogic scale

    Measured: after the colonoscopy

  3. The mean patient satisfaction on a visual analogic scale.

    Measured: after the colonoscopy

  4. The percentage of patients who agree to repeat the procedure in similar circumstances.

    Measured: after the colonoscopy

  5. The grade of difficulty of the colonoscopy evaluated by the endoscopist

    Measured: After the colonoscopy

  6. The mean duration of the endoscopy

    Measured: After the colonoscopy

  7. The percentage of caecum intubation

    Measured: After the colonoscopy

  8. The percentage of ileal intubation

    Measured: After the colonoscopy

  9. The opinion of the endoscopist on the tolerance of the colonoscopy

    Measured: After the colonoscopy

  10. The time to hospital discharge

    Measured: After the issue of the colonoscopy

  11. The Aldrete's score at the hospital discharge

    Measured: After the colonoscopy

  12. The number of patient who have refused the inclusion

    Measured: After the issue of the colonoscopy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jun 2009 (estimated)
  2. Study startFeb 2009
  3. Primary completionJan 2011
  4. Study completionJan 2011

Why it stopped: This study was stopped due to low inclusion

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
220 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00930358
Sponsor's protocol ID
P060240
Acronym
KALINAG
Status last verified
Apr 2011
First submitted
29 Jun 2009
Last updated
6 Apr 2011
Results posted
No
Data monitoring committee
Yes

Publications

  • Trojan J, Saunders BP, Woloshynowych M, Debinsky HS, Williams CB. Immediate recovery of psychomotor function after patient-administered nitrous oxide/oxygen inhalation for colonoscopy. Endoscopy. 1997 Jan;29(1):17-22. doi: 10.1055/s-2007-1004055.

    PubMed 9083731

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing MEOPA and general anaesthesia in people with Colonoscopy Procedure, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 6 Apr 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was stopped early (reason given: This study was stopped due to low inclusion). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of patients who have well tolerated the colonoscopy as assessed by visual analogic scale (>75/100) (time frame: Immediately after the colonoscopy). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00930358, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2011; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in